Joe Rogan Experience #2469 - Brigham Buhler

| Podcasts | March 18, 2026 | 389 Thousand views | 2:22:02

TL;DR

Brigham Buhler details ongoing FDA efforts to reclassify peptides and remove black box warnings from hormone therapy under Secretary Kennedy and Dr. Marty Makary, exposing how a flawed 1930s study created decades of testosterone misinformation while the billion-dollar drug approval process systematically blocks accessible preventative medicine.

🏛️ FDA Reform & Peptide Regulation 2 insights

New administration reversing peptide restrictions

After submitting 17 unanswered FOIA requests to the prior administration, Buhler reports that Secretary Kennedy and FDA head Marty Makary are now actively working to reclassify peptides, utilizing over 800 provided safety studies to counter the previous FDA's "Trojan horse" classification of these molecules as dangerous.

Peptides blocked by pharmaceutical economics

Peptides occupy a regulatory "no man's land" because they are natural, unpatentable molecules that cannot sustain the $1-3 billion drug approval process designed for Big Pharma, forcing them to remain cash-pay options outside the insurance ecosystem that regulators are accustomed to navigating.

⚕️ Debunking Testosterone Myths 2 insights

1930s study with three patients created false dogma

The widespread medical belief that testosterone causes prostate cancer originated from a 1930s study of just three patients—one of whom was chemically castrated—which was definitively debunked by urologist Dr. Morgan Tyler in the 1990s yet persisted as unchallenged dogma for nearly a century.

FDA removing hormone therapy warnings

Under Admiral Brian Christine and Dr. Makary, the FDA now recognizes that optimal testosterone levels do not cause prostate cancer and is actively working to remove black box warnings from hormone replacement therapies for both men and women.

🏥 Structural Healthcare Failures 2 insights

Medical dogma mistaken for consensus

Citing Dr. Makary's book "Blind Spot," Buhler argues that medicine frequently confuses academic groupthink and peer pressure with scientific consensus, allowing debunked misinformation to become "urban legend" that doctors regurgitate without examining primary sources.

System incentivizes chronic disease over prevention

The billion-dollar cost to bring drugs to market creates a protective moat for pharmaceutical companies that inherently limits innovation in preventative, personalized medicine while ensuring the system remains optimized for monetizing chronic disease rather than preventing it.

Bottom Line

The medical regulatory system has prioritized protecting Big Pharma's profit model and defending outdated dogma over patient health, but new FDA leadership is finally dismantling decades of misinformation by removing testosterone warnings and reclassifying peptides based on actual clinical evidence rather than flawed historical studies.

More from Joe Rogan Experience

View all
Joe Rogan Experience #2496 - Julia Mossbridge
2:42:43
Joe Rogan Experience Joe Rogan Experience

Joe Rogan Experience #2496 - Julia Mossbridge

Cognitive neuroscientist Julia Mossbridge joins Joe Rogan to discuss her research into precognition and psychic phenomena, revealing how academic institutions actively suppress fringe science while exploring how long-form media and a willingness to be 'foolish' are shifting culture away from ego-driven expertise toward childlike curiosity.

1 day ago · 9 points
Joe Rogan Experience #2494 - Chamath Palihapitiya
2:45:55
Joe Rogan Experience Joe Rogan Experience

Joe Rogan Experience #2494 - Chamath Palihapitiya

Chamath Palihapitiya argues that societal unrest stems from a structural economic imbalance where capital gains are taxed less than labor, enabled by technology that extracts value without workers, while contemporary debates about AI and UAPs distract from this core issue; Rogan counters that government incompetence and waste make taxation-based solutions untenable.

4 days ago · 9 points
Joe Rogan Experience #2492 - Ari Shaffir
2:35:36
Joe Rogan Experience Joe Rogan Experience

Joe Rogan Experience #2492 - Ari Shaffir

Joe Rogan and Ari Shaffir discuss Ari's seven-month South American travels, share intense stories about unregulated psychedelic experiences revealing human nature, and explore Texas's groundbreaking $100 million Ibogaine initiative for treating addiction and veteran PTSD.

9 days ago · 9 points
Joe Rogan Experience #2491 - Brian Simpson
2:32:21
Joe Rogan Experience Joe Rogan Experience

Joe Rogan Experience #2491 - Brian Simpson

Comedian Brian Simpson recounts surviving a heart attack three months ago and clashing with medical staff over humor-based coping mechanisms, while he and Joe Rogan discuss vision improvement through red light therapy, predatory veterinary billing practices, and the untrainable nature of wolves compared to domestic dogs.

10 days ago · 7 points